What is appropriate treatment for carcinoma of the thoracic esophagus?

World Journal of Surgery

Volumn 25, Issue 2, 2001, Pages 189-195

  Law, Simon ^a   Wong, John ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; RADIATION INJURY; REVIEW; SIDE EFFECT; SURGICAL APPROACH;

ADENOCARCINOMA; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 0035053806     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002680020018     Document Type: Review

References (86)

1. Transhiatal oesophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of oesophageal cancer
2. Transthoracic esophagectomy: A safe approach to carcinoma of the esophagus
3. Esophagectomy with or without thoracotomy: Is there any difference?
4. Transthoracic versus extrathoracic esophagectomy: Mortality, morbidity, and long term survival
5. Carcinoma of the esophagus: A comparison of the results of transhiatal versus transthoracic resection
6. A comparison of transhiatal and transthoracic resection for oesophageal carcinoma
7. Transhiatal and transthoracic esophagectomy: A comparative study
8. Transhiatal oesophagectomy: Its role for tumours of the middle third of the intrathoracic oesophagus
9. Complications of transhiatal esophagectomy
10. Transhiatal esophagectomy: Clinical experience and refinements
11. Postoperative analgesia reduces mortality and morbidity after esophagectomy
12. Oesophagectomy by a transhiatal approach or thoracotomy: A prospective randomized trial
13. A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma
14. Transhiatal versus Ivor-Lewis oesophagectomy: Is there a difference?
15. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma
16. Adenocarcinoma of the gastroesophageal junction: Classification, pathology and extent of resection
17. Radical transhiatal oesophagectomy under direct vision
18. Transhiatal esophagectomy for esophageal cancer
19. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia
20. Thoracoscopic esophagectomy for esophageal cancer
21. Can the morbidity of esophagectomy be reduced by the thoracoscopic approach?
22. Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy
23. Endoscopic oesophagectomy through a right thoracoscopic approach
24. En bloc and standard esophagectomies by thoracoscopy
25. Radical thoracoscopic esophagectomy for cancer
26. Thoracoscoic dissection of the esophagus for cancer
27. Video-assisted thoracoscopic esophagectomy for esophageal cancer
28. As originally published in 1993: En bloc and standard esophagectomies by thoracoscopy; updated in 1996
29. Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning
30. A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the esophagus and cardia
31. The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer
32. Shrinkage of the esophagus after resection for carcinoma
33. pTNM and residual tumor classifications: Problems of assessment and prognostic significance
34. Significance of circumferential resection margin involvement after oesophagectomy for cancer
35. Selection of operation for esophageal cancer based on staging
36. Selective therapeutic approach to cancer of the lower esophagus and cardia
37. Results of a nationwide study on the three fields of lymph node dissection in esophageal cancer
38. Radical lymph node dissection for cancer of the thoracic esophagus
39. Endosonographic staging of esophageal cancer: A review of literature results
40. Esophageal carcinoma: Current controversies
41. Transhiatal esophagectomy for benign and malignant disease
42. En bloc esophagectomy: The first 100 patients
43. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy
44. Quality of life and patterns of recurrence following transhiatal esophagectomy for cancer: Results of a prospective follow-up in 50 patients
45. En bloc esophagectomy improves survival for stage III esophageal cancer
46. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma
47. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus
48. Long term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus
49. Evaluating the rational extent of dissection in radical esophagectomy for invasive carcinoma of the thoracic esophagus
50. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer: Comparison of three-field lymphadenectomy with two-field lymphadenectomy
51. Outcomes of extended radical esophagectomy for thoracic esophageal cancer
52. Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction
53. Occult cervical nodal metastasis in esophageal cancer: Preliminary results of three-field lymphadenectomy
54. Quality of life following esophagectomy with three-field lymphadenectomy for carcinoma, focusing on its relationship to vocal cord palsy
55. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
56. Resective surgery for cancer of the thoracic esophagus: Results of a consensus conference held at the VIth World Congress of the International Society for Diseases of the Esophagus
57. Multimodal therapy for squamous carcinoma of the oesophagus
58. Preoperative radiotherapy for carcinoma of the esophagus
59. The value of preoperative radiotherapy in esophageal cancer: Results of a study of the E.O.R.T.C.
60. Randomized clinical trial on the combination of pre-operative irradiation and surgery in the treatment of esophageal carcinoma: Report on 206 patients
61. Low dose preoperative radiotherapy for carcinoma of the oesophagus: Results of a randomized clinical trial
62. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of preoperative radiotherapy and chemotherapy: The second Scandinavian trial in esophageal cancer
63. Combined preoperative irradiation and surgery versus surgery alone for squamous cell carcinoma of the midthoracic esophagus: A prospective randomized study in 360 patients
64. Postoperative radiotherapy for carcinoma of the esophagus: A prospective, randomized controlled study
65. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial
66. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: A prospective randomized study
67. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus: The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie study group
68. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus
69. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial
70. Neoadjuvant chemotherapy compared with surgery in esophageal squamous cell cancer
71. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
72. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: The Japan Clinical Oncology Group study
73. 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus: A multicenter randomized trial; French Associations for Surgical Research
74. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus
75. A prospective study of combined therapy in esophageal cancer
76. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
77. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus
78. A randomized trial comparing surgery (S) to preoperative concomitant chemoradiation plus surgery in patients (pts) with resectable esophageal cancer (CA): Updated analysis
79. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
80. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study
81. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01): Radiation Therapy Oncology Group
82. The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: Results of the 1992-1994 Patterns of Care Study
83. Esophageal cancer: Results of an American College of Surgeons Patient Care Evaluation Study
84. Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy
85. Multimodal treatment for squamous cell esophageal cancer
86. Cancer surgery: Why some survival benefits may be artifactual